Invitrogen Buys Protein Chip Maker Protometrix

NEW YORK, April 2 (GenomeWeb News) - Invitrogen has acquired protein microarray company Protometrix, the companies said today.

Invitrogen said it will offer Protometrix's first product, a yeast proteome chip, this summer. Protometrix started selling its Yeast ProtoArray chip last fall.

In addition, Invitrogen plans to introduce protein microarrays for analyzing human kinase interactions and activity in the second half of the year. Furthermore, the company intends to develop arrays for diagnostics, biomarkers and biodefense research, and testing drug interactions and side effects. Invitrogen hopes the acquisition will add $3-5 million to its revenues this year.

Protometrix, based in Branford, Conn., was founded in 2001 based on technology developed by Michael Snyder at Yale University.